Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| P30AI050409 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
We will invite a convenience sample of up to 45 enrolled subjects to participate in an optional, self-administered blood specimen collection procedure to determine optimal procedures for collection.
Participants will be recruited to this one-time assessment during their follow-up visits. After completing a consent procedure specific to this study component, participants will be provided with instructions on how to fully self-administer the procedure of a finger stick and also blotting to collect a blood specimen using a 1, 3 or 5 blood spot specimen collection card. These specimens will be labeled with the participant's unique identification number, and no other identifying information. The dried blood spots will be evaluated by a laboratorian to assess quality, but will not be tested for HIV. This evaluation will help determine what number of self-collected dried blood spots yields the highest usable quantity of sample for HIV testing. There will be a separate monetary incentive of $30 for this procedure.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 Dried Blood Spot (DBS) | Number of DBS Spots Participants will be asked to fill one spot on a dried blood spot collection card. |
| |
| 3 DBS Spots | Number of DBS Spots Participants will be asked to fill three spots on a dried blood spot collection card. |
| |
| 5 DBS Sports | Number of DBS Spots Participants will be asked to fill five spots on a dried blood spot collection card. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Number of DBS Spots | Other | The number of DBS spots on the card constitutes the experimental condition. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Viable sample for HIV Testing | Samples will be examined and not tested by a lab technician for acceptability for HIV testing. | Outcome measure will be assessed with in two weeks of all samples being collected |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Participants will be enrolled or previously enrolled in the InvolveMENt Study through Emory University. They will be assesed for study interest either at the end of their scheduled appointment with InvolveMENt, or will be contacted if consent to contact them for future studies was previously obtained through InvolveMENt.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| AD McNaghten, PHD, MHSA | Emory University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Emory University | Atlanta | Georgia | 30322 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Dried blood spots will be collected and inspected for quality. Once quality is determined, samples will be destroyed. No identifying information will be associated with the sample.